DROPIZOL

This brand name is authorized in Austria, Finland, Ireland, Netherlands, Romania, United Kingdom

Active ingredients

The drug DROPIZOL contains one active pharmaceutical ingredient (API):

1 Opium UNII 37M3MZ001L - OPIUM

Opium alkaloids (opioids and isoquinoline derivatives) induce constipation, euphoria, analgesia and sedation dependent on the dose and derivative. The constipating effect is caused by inhibition of the intestines' peristalsis. Read about Opium

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
DROPIZOL Oral drops, solution	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A07DA02	Opium	A Alimentary tract and metabolism → A07 Antidiarrheals, intestinal antiinflammatory/antiinfective agents → A07D Antipropulsives → A07DA Antipropulsives
Discover more medicines within A07DA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 044780, 480553
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 371230
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 202037
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W68999001, W68999002, W68999003, W68999004, W68999005, W68999006